Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 9/20 | 0.47 |
| ▸ | FAAH | O00519 | 4/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | PKM | P14618 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | APEX1 | P27695 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28987712 | 0.88 | ALDH1A1 (0.51) | L3MBTL1MAPTKMT2AMEN1ALDH1A1 | |
| SCHEMBL9644486 | 0.84 | MGLL (0.42) | MGLLFAAHL3MBTL1HSP90AA1MAPT | |
| SCHEMBL2222585 | 0.83 | DDAH1 (0.51) | MGLLFAAHL3MBTL1HSP90AA1APOBEC3G | |
| SCHEMBL31022582 | 0.81 | GAA (0.44) | MGLLFAAHL3MBTL1HSP90AA1MAPT | |
| SCHEMBL30515182 | 0.81 | KMT2A (0.46) | MGLLFAAHL3MBTL1HSP90AA1MAPT | |
| SCHEMBL10583734 | 0.80 | L3MBTL1 (0.36) | L3MBTL1KMT2AMEN1ALDH1A1PKM | |
| SCHEMBL10829139 | 0.77 | MGLL (0.46) | MGLLFAAHL3MBTL1HSP90AA1MAPT | |
| SCHEMBL30721675 | 0.77 | MGLL (0.46) | MGLLFAAHL3MBTL1HSP90AA1MAPT | |
| SCHEMBL5157148 | 0.77 | KMT2A (0.51) | MGLLFAAHL3MBTL1HSP90AA1MAPT | |
| SCHEMBL6323222 | 0.76 | MGLL (0.45) | MGLLFAAHL3MBTL1HSP90AA1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 735 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260132397-A1 | IMMOBILIZED ENZYMES FOR BIOELECTROCATALYSIS | ANODYNE CHEMISTRIES INC (CA) | 2026-05-14 | — | — | US | claimed |
| US-12516311-B2 | Immobilized enzymes for bioelectrocatalysis | ANODYNE CHEMISTRIES, INC. (CA) | 2026-01-06 | — | — | US | claimed |
| WO-2024109840-A1 | FUSED RING COMPOUND, CONJUGATE THEREOF AND USE THEREOF | 康诺亚生物医药科技（成都）有限公司 | 2024-05-30 | — | — | WO | claimed |
| EP-2804631-B1 | SURROBODY CONJUGATES | I2 PHARMACEUTICALS INC (US) | 2021-03-17 | — | — | EP | claimed |
| EP-3246698-B1 | ELECTROCHEMICAL BIOSENSORS | ELISHA SYSTEMS LTD (GB) | 2019-05-08 | — | — | EP | claimed |
| EP-2437790-B1 | CONJUGATION METHODS | IMMUNOGEN INC (US) | 2019-02-20 | — | — | EP | claimed |
| EP-2197783-B1 | COMPLEX OF CELL TRANSLOCATIONAL PEPTIDE AND MAGNETIC NANOPARTICLES AND USE THEREOF | SEOUL NATIONAL UNIV INDUSTRY FOUNDATION (KR) | 2018-07-11 | — | — | EP | claimed |
| EP-2494075-B1 | TEMPLATED NANOCONJUGATES | UNIV NORTHWESTERN (US) | 2018-04-04 | — | — | EP | claimed |
| EP-2056871-B1 | PROTEIN MATRIX VACCINES AND METHODS OF MAKING AND ADMINISTERING SUCH VACCINES | HARVARD COLLEGE (US) | 2017-11-15 | — | — | EP | claimed |
| EP-2686019-B1 | CONJUGATED MOLECULES COMPRISING A PEPTIDE DERIVED FROM THE CD4 RECEPTOR COUPLED TO A POLYANIONIC POLYPEPTIDE FOR THE TREATMENT OF AIDS | PASTEUR INSTITUT (FR) | 2017-03-01 | — | — | EP | claimed |
| EP-0816364-B1 | Reagents for lysergic acid diethylamide immunoassay | HOFFMANN LA ROCHE (CH) | 2004-01-02 | — | — | EP | claimed |
| US-6436652-B1 | CONJUGATING WILD-TYPE BACTERIOPHAGE SPECIFIC TO BRUCELLA BACTERIA TO ACTIVE UREASE ENZYME; COUPLING WITH M-MALEIMIDOBENZOYL-N-HYDROXYSUCCINIMIDE | HER MAJESTY THE QUEEN IN RIGHT OF CANADA, AS REPRESENTED BY THE MINISTER OF NATIONAL DEFENCE OF HER MAJESTY'S CANADIAN GOVERNMENT (CA) | 2002-08-20 | — | — | US | claimed |
| US-6235886-B1 | OLIGONUCLEOTIDES | ISIS PHARMACEUTICALS, INC. | 2001-05-22 | — | — | US | claimed |
| EP-0396116-B1 | Covalent attachment of specific binding members to a solid phase | ABBOTT LAB (US) | 1997-02-05 | — | — | EP | claimed |
| US-5208021-A | Deactivation and linking, mixing and incubation | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1993-05-04 | — | — | US | claimed |
| EP-0310716-B1 | A PRODUCT, PREPARATION AND METHOD FOR TREATING ALLERGIES | IMMUNET (US) | 1993-03-10 | — | — | EP | claimed |
| EP-0065320-B1 | COUPLING PROCESS OF A MEDICAMENT TO A THIOLATED POLYPEPTIDIC COMPOUND COMING FROM A FRAGMENT OF THE TETANIC TOXINE, AND ITS USES | INSTITUT PASTEUR (FR) | 1985-04-03 | — | — | EP | claimed |
| EP-0065320-A1 | Coupling process of a medicament to a thiolated polypeptidic compound coming from a fragment of the tetanic toxine, and its uses | INSTITUT PASTEUR (FR) | 1982-11-24 | — | — | EP | claimed |
| EP-0057140-A2 | Thiolated polypeptidic compound from a tetanic toxin fragment, process for its production and its applications | INSTITUT PASTEUR (FR) | 1982-08-04 | — | — | EP | claimed |
| EP-0030496-A1 | Thiolated polypeptidic compound coming from a fragment of tetanic toxine, process for obtaining it and its applications | INSTITUT PASTEUR (FR) | 1981-06-17 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260132397-A1 | IMMOBILIZED ENZYMES FOR BIOELECTROCATALYSIS | AGL, SOD1, BTD | MGLL 1115/4885FAAH 4481/4885L3MBTL1 1710/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.